Log In
Print
BCIQ
Print
Print this Print this
 

biglycan (TVN-102)

  Manage Alerts
Collapse Summary General Information
Company Tivorsan Pharmaceuticals Inc.
DescriptionRecombinant human biglycan (rhBGN)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today